Genmab A GMAB
NASDAQ GMAB
$43.40 +3.40 (+8.51%)
As of: Oct 23, 2026 · 2:46 PM EDT

Genmab A (GMAB) Other Investing Activities (2023 - 2026)

Updated

Analysis

Genmab A (GMAB) Other Investing Activities (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other investing (Qtr)
1 Eli Lilly 1,124.12 Bn 1,092.71 Bn 19.71 Bn -127.00 Mn
2 Johnson & Johnson 634.38 Bn 554.24 Bn 17.30 Bn 352.00 Mn
3 AbbVie 505.39 Bn 478.50 Bn 12.70 Bn -51.00 Mn
4 Merck 357.36 Bn 311.74 Bn 12.21 Bn -22.00 Mn
5 Novartis Ag 290.21 Bn 254.20 Bn 11.24 Bn 218.00 Mn
6 Astrazeneca 265.21 Bn 238.89 Bn 12.86 Bn 174.00 Mn
7 Amgen 237.81 Bn 193.21 Bn 7.24 Bn -56.00 Mn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn 20.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -1.00 Mn
10 Genmab A 2.79 Bn -2.58 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.00 Mn
Mar 31, 2025 -1.00 Mn
Mar 31, 2024 -3.00 Mn
Dec 31, 2023 17.00 Mn
Mar 31, 2023 -2.00 Mn
API Access

Genmab A Other Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-investing-activities&ticker=GMAB&period=max&api_key=YOUR_API_KEY